Boulevard raises $80M to power self-care boom driven by Botox and GLP-1 surge

Boulevard, a software provider for the self-care sector, recently secured $80 million in Series D funding, valuing the company at nearly $800 million, a substantial increase from its $595 million valuation three years prior. This funding round, led by JMI Equity, underscores Boulevard's significant growth, driven by a 500%+ revenue surge over the past three years, primarily from its strategic expansion into the burgeoning MedSpa market, where it now powers approximately 15% of U.S. facilities. The company, which also processes an estimated $5 billion in payments annually, is capitalizing on the industry's shift towards cash-pay models and the blurring lines between beauty and medical services.

Analysis

Boulevard has secured $80 million in a Series D funding round, elevating its valuation to nearly $800 million, a material increase from its $595 million valuation three years prior. This growth is underpinned by a revenue surge of over 500% during the same period, primarily driven by a successful expansion into the MedSpa market. The company astutely identified a gap where cash-pay MedSpas were poorly served by traditional insurance-focused electronic medical records systems, allowing Boulevard to capture an estimated 15% of the U.S. MedSpa market by adapting its platform with HIPAA compliance and specialized features. Furthermore, Boulevard has organically developed a significant fintech component to its business model, evolving from a simple no-show prevention feature to a payment processor expected to handle approximately $5 billion in transactions this year. Despite this strong performance and a clear product-market fit in a booming industry where beauty and medical services are converging, the company operates in a competitive landscape with rivals including Zenoti, which was valued at $1 billion in 2020.

Key Decisions for Investors

• Private equity and venture investors should view Boulevard's latest funding round, led by growth equity firm JMI Equity, as a strong validation of its vertical SaaS strategy and leadership in the high-growth self-care technology space.
• Consider Boulevard a key 'picks-and-shovels' play on the secular trend of converging beauty and minimally invasive medical services, a market characterized by strong consumer demand and a shift to cash-pay models.
• Investors should monitor Boulevard's ability to defend its market share against well-funded competitors and continue its revenue diversification through its integrated payments platform, as these factors will be critical for justifying its valuation in a future liquidity event.